Zogenix International Limited, Inc., a subsidiary of Zogenix

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Zogenix International Limited, Inc., a subsidiary of Zogenix sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials none currently recruiting 5 completed later-stage tilt upper quartile by trial count

Zogenix International Limited, Inc., a subsidiary of Zogenix: 6 sponsored US clinical trials, none currently recruiting.

Zogenix International Limited, Inc., a subsidiary of Zogenix sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 5 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Dravet Syndrome, with 1 trials.

Upper-quartile sponsor footprint

Zogenix International Limited, Inc., a subsidiary of Zogenix sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

6 total, page 1 of 1

COMPLETED Phase 1

A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol

NCT03467113
COMPLETED Phase 3

A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome

NCT03355209
TERMINATED Phase 3

A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

NCT03299842
COMPLETED Phase 3

A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome

NCT02926898
COMPLETED Phase 3

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

NCT02823145
COMPLETED Phase 3

A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

NCT02682927

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 5

Therapeutic Areas

Dravet Syndrome 1
Lennox Gastaut Syndrome 1

How the Zogenix International Limited, Inc., a subsidiary of Zogenix archive is shaped

6 indexed studies, none listed as recruiting (0% open); 5 completed (83%).

Phase mix: 5 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Dravet Syndrome (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Zogenix International Limited, Inc., a subsidiary of Zogenix: archived-pipeline peers nationwide

Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Zogenix International Limited, Inc., a subsidiary of Zogenix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60%80% Total trials Recruiting share Zogenix International Limited, Inc., a subsidiary of Zogenix23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan Branch10xBio22nd Century Group3-C Institute for Social Development3 Waves Wellness
Zogenix International Limited, Inc., a subsidiary of Zogenix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Zogenix International Limited, Inc., a subsidiary of Zogenix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Zogenix International Limited, Inc., a subsidiary of Zogenix page

6 registered trials is a research-attention snapshot, not an endorsement of Zogenix International Limited, Inc., a subsidiary of Zogenix or any single study.

  • None of Zogenix International Limited, Inc., a subsidiary of Zogenix's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Dravet Syndrome is the condition Zogenix International Limited, Inc., a subsidiary of Zogenix studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Dravet Syndrome trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Zogenix International Limited, Inc., a subsidiary of Zogenix pipeline card: 6 registered trials from official public datasets.Report a data error.